INTERLEUKIN-1-BETA INDUCES CORTICOTROPIN-RELEASING FACTOR-41 RELEASE FROM CULTURED HYPOTHALAMIC CELLS THROUGH PROTEIN-KINASE-C AND CAMP-DEPENDENT PROTEIN-KINASE PATHWAYS
被引:22
作者:
HU, SB
论文数: 0引用数: 0
h-index: 0
机构:Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London
HU, SB
TANNAHILL, LA
论文数: 0引用数: 0
h-index: 0
机构:Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London
TANNAHILL, LA
LIGHTMAN, SL
论文数: 0引用数: 0
h-index: 0
机构:Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London
LIGHTMAN, SL
机构:
[1] Neuroendocrinology Unit, Charing Cross and Westminster Medical School, Charing Cross Hospital, London
INTERLEUKIN-1-BETA;
CORTICOTROPIN-RELEASING FACTOR-41;
PROTEIN KINASE-C;
CAMP-DEPENDENT PROTEIN KINASE;
DEXAMETHASONE;
D O I:
10.1016/0165-5728(92)90212-4
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
Interleukin-1-beta (IL-1-beta) induces a dose-dependent increase in the release of corticotropin-releasing factor-41 (CRF) from dispersed rat fetal hypothalamic cells in culture. This release of CRF could be inhibited by the protein kinase C inhibitor H-7, and by the protein kinase A inhibitor IP-20. This suggests that both protein kinase C and protein kinase A-dependent pathways are involved in the response of CRF to IL-1-beta. Dexamethasone also blocked the CRF response to IL-1-beta, indicating that activated glucocorticoid receptors can inhibit the response of CRF to IL-1-beta.